Literature DB >> 11932425

Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation.

Tatsuya Sakai1, Reiko Ohuchi, Masanobu Ohuchi.   

Abstract

Influenza virus hemagglutinin (HA) has three highly conserved acylation sites close to the carboxyl terminus of the HA2 subunit, one in the transmembrane domain and two in the cytoplasmic domain. Each site is modified by palmitic acid through a thioester linkage to cysteine. To elucidate the biological significance of HA acylation, the acylation sites of HA of influenza virus strain A/USSR/77 (H1N1) were changed by site-directed mutagenesis, and the membrane fusion activity of mutant HAs lacking the acylation site(s) was examined quantitatively using transfer assays of lipid (R18) and aqueous (calcein) dyes. Lipid mixing, so-called hemifusion, activity was not affected by deacylation, whereas transfer of aqueous dye, so-called fusion pore formation, was dramatically restricted. When the fusion reaction was induced by a lower pH than the optimal one, calcein transfer with the mutant HAs was improved, but simultaneously a considerable calcein leakage into the medium was observed. From these results, we conclude that the palmitic acids on the H1 subtype HA facilitate the transition from hemifusion to fusion pore formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932425      PMCID: PMC155084          DOI: 10.1128/jvi.76.9.4603-4611.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.

Authors:  G B Melikyan; R M Markosyan; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

2.  Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.

Authors:  D A Steinhauer; S A Wharton; D C Wiley; J J Skehel
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

3.  Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.

Authors:  D A Simpson; R A Lamb
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

4.  Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density.

Authors:  H Ellens; J Bentz; D Mason; F Zhang; J M White
Journal:  Biochemistry       Date:  1990-10-16       Impact factor: 3.162

5.  Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin.

Authors:  M Veit; E Kretzschmar; K Kuroda; W Garten; M F Schmidt; H D Klenk; R Rott
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Infectious cell entry mechanism of influenza virus.

Authors:  A Yoshimura; K Kuroda; K Kawasaki; S Yamashina; T Maeda; S Ohnishi
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Enhancement of influenza virus hemolysis by physical and serological treatments.

Authors:  Y Watanabe; M Tashiro; F Kitame; M Homma
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

8.  Fatty acids on the A/Japan/305/57 influenza virus hemagglutinin have a role in membrane fusion.

Authors:  C W Naeve; D Williams
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

9.  The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.

Authors:  R T Armstrong; A S Kushnir; J M White
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

Review 10.  The molecular biology of influenza virus pathogenicity.

Authors:  H D Klenk; R Rott
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

View more
  27 in total

1.  The SNARE Ykt6 mediates protein palmitoylation during an early stage of homotypic vacuole fusion.

Authors:  Lars E P Dietrich; Rolf Gurezka; Michael Veit; Christian Ungermann
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

2.  Membrane permeability changes at early stages of influenza hemagglutinin-mediated fusion.

Authors:  V A Frolov; A Y Dunina-Barkovskaya; A V Samsonov; J Zimmerberg
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

3.  Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics.

Authors:  Jianqiang Zhou; Shun Xu; Jun Ma; Wen Lei; Kang Liu; Qiliang Liu; Yida Ren; Chunyi Xue; Yongchang Cao
Journal:  Virus Genes       Date:  2013-11-23       Impact factor: 2.332

4.  Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.

Authors:  Rene Broer; Bertrand Boson; Willy Spaan; François-Loïc Cosset; Jeroen Corver
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 5.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

6.  Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression.

Authors:  Min Li; Chinglai Yang; Suxiang Tong; Armin Weidmann; Richard W Compans
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 7.  Protein-lipid interactions critical to replication of the influenza A virus.

Authors:  Petr Chlanda; Joshua Zimmerberg
Journal:  FEBS Lett       Date:  2016-03-30       Impact factor: 4.124

8.  Site-specific S-acylation of influenza virus hemagglutinin: the location of the acylation site relative to the membrane border is the decisive factor for attachment of stearate.

Authors:  Katharina Brett; Larisa V Kordyukova; Marina V Serebryakova; Ramil R Mintaev; Andrei V Alexeevski; Michael Veit
Journal:  J Biol Chem       Date:  2014-10-27       Impact factor: 5.157

9.  Role of spike protein endodomains in regulating coronavirus entry.

Authors:  Ana Shulla; Tom Gallagher
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

10.  Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry.

Authors:  Jeroen Corver; Rene Broer; Puck van Kasteren; Willy Spaan
Journal:  Virol J       Date:  2009-12-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.